CLIN Clinigen Group Plc

TIDMCLIN

RNS Number : 7459X

Clinigen Group plc

28 November 2017

28 November 2017

Result of AGM

Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, held its Annual General Meeting ("AGM") at 10.00am today. All resolutions were passed.

At the meeting, Peter Allen, Clinigen's Chairman reiterated that the Group is well positioned to deliver another good year of progress, as set out at the recent full year results.

The slides from the presentation given by the Group will be made available on Clinigen's website www.clinigengroup.com.

- Ends-

 
 Clinigen Group plc                  Tel: +44 (0) 1283 
                                      495 010 
 Shaun Chilton, Group Chief 
  Executive Officer 
  Martin Abell, Group Chief 
  Financial Officer 
 Matt Parrish, Head of Investor 
  Relations 
 
 Numis Securities Limited            Tel: +44 (0) 20 7260 
                                      1000 
 Michael Meade / Freddie Barnfield 
  (Nominated Adviser) 
  James Black / Tom Ballard 
  (Corporate Broking) 
 
 RBC Capital Markets - Joint         Tel: +44 (0) 20 7653 
  Broker                              4000 
 Marcus Jackson / Elliot Thomas 
  / Jack Wood 
 
 Instinctif Partners (media          Tel: +44 (0) 20 7457 
  relations)                          2020 
 Melanie Toyne-Sewell / Alex 
  Shaw / Deborah Bell                Email: clinigen@instinctif.com 
 

About Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen acquired Quantum Pharma in November 2017.

For more information, please visit www.clinigengroup.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGUWRURBUAAUAA

(END) Dow Jones Newswires

November 28, 2017 07:03 ET (12:03 GMT)

Clinigen (LSE:CLIN)
Historical Stock Chart
From Mar 2024 to Apr 2024

Clinigen (LSE:CLIN)
Historical Stock Chart
From Apr 2023 to Apr 2024